Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2-adrenoceptor in CRISPR/Cas9 genome-edited HEK293T cells at low expression levels

Fluorescent ligand technologies have proved to be powerful tools to improve our understanding of ligand-receptor interactions. Here we have characterized a small focused library of nine fluorescent ligands based on the highly selective beta(2)-adrenoceptor (beta(2)AR) antagonist ICI 118,551. The majority of fluorescent ICI 118,551 analogs had good affinity for the beta(2)AR (pK(D) >7.0) with good selectivity over the beta(1)AR (pK(D) <6.0). The most potent and selective ligands being 8c (ICI 118,551-Gly-Ala-BODIPY-FL-X; beta(2)AR pK(D) 7.48), 9c (ICI 118,551-beta Ala-beta Ala-BODIPY-FL-X; beta(2)AR pK(D) 7.48), 12a (ICI 118,551-PEG-BODIPY-X-630/650; beta(2)AR pK(D) 7.56), and 12b (ICI 118,551-PEG-BODIPY-FL; beta(2)AR pK(D) 7.42). 9a (ICI 118,551-beta Ala-beta Ala-BODIPY-X-630/650) had the highest affinity at recombinant beta(2)ARs (pK(D) 7.57), but also exhibited significant binding affinity to the beta(1)AR (pK(D) 6.69). Nevertheless, among the red fluorescent ligands, 9a had the best imaging characteristics in recombinant HEK293 T cells and labeling was mostly confined to the cell surface. In contrast, 12a showed the highest propensity to label intracellular beta(2)ARs in HEK293 T cell expressing exogenous beta(2)ARs. This suggests that a combination of the polyethylene glycol (PEG) linker and the BODIPY-X-630/650 makes this ICI 118,551 derivative particularly susceptible to crossing the cell membrane to access the intracellular beta(2)ARs. We have also used these ligands in combination with CRISPR/Cas9 genome-edited HEK293 T cells to undertake for the first time real-time ligand binding to native HEK293 T beta(2)ARs at low native receptor expression levels. These studies provided quantitative data on ligand-binding characteristics but also allowed real-time visualization of the ligand-binding interactions in genome-edited cells using NanoBRET luminescence imaging.